Neuropharmacological and Clinical Aspects of Alcohol Withdrawal

References

• Victor M, Adams R D. The effects of alcohol on the nervous system. Res Publ Assoc Res Nerv Ment Dis 1953; 32: 526–73
   PubMedGoogle Scholar
• Daniell L C., Brass E P., Harris R A. Effect of ethanol on in-tracellular ionized calcium concentrations in synapto-somes and hepatocytes. Mol Pharmacol 1987; 32: 831–7
   Google Scholar
• Lynch M A., Littleton J M. Possible association of alcohol tolerance with increased synaptic Ca sensitivity. Nature 1983; 303: 175–7
   Google Scholar
• Dolin S J., Little H J., Hudspith M, Pagonis S, Littleton J. Increased dihydropyridine-sensitive calcium channels in rat brain may underlie ethanol physical dependence. Neuropharmacology 1987; 26: 275–9
   PubMed Web of Science ®Google Scholar
• Littleton J. Alcohol intoxication and physical dependence: a molecular mystery tour. Br J Addict 1989; 84: 267–76
   Google Scholar
• Little H J., Dolin S J., Halsey M J. Calcium channel antagonists decrease the ethanol withdrawal syndrome in rats. Life Sci 1986; 39: 2059–65
   PubMed Web of Science ®Google Scholar
• Koppi S, Eberhardt G, Haller R, Konig P. Calcium channel blocking agent in the treatment of acute alcohol withdrawal - caroverine versus meprobamate in a randomised double blind study. Neuropsychobiology 1987; 17: 49–52
   PubMed Web of Science ®Google Scholar
• Littleton J M., Little H J. Dihydropyridine-sensitive Ca channels in brain are involved in the central nervous system hyperexcitability associated with alcohol withdrawal states. Ann N Y Acad Sci 1988; 522: 199–202
   Google Scholar
• Dolin S J., Little H J. Calcium antagonists during ethanol administration. J Pharmacol Exp Ther 1990, (in press)
   Google Scholar
• Whittington M A., Little H J. Nitrendipine prevents the ethanol withdrawal syndrome when administered chronically with ethanol prior to withdrawal. Br J Pharmacol 1989; 94: 385P
   Google Scholar
• Ticku M K., Burch T P., Davis W C. The interactions of ethanol with the benzodiazepine-GABA receptor-iono-phore complex. Pharmacol Biochem Behav 1983; 18: 15–18
   Google Scholar
• Banna N R. Potentiation of cutaneous inhibition by ethanol. Experientia 1969; 25: 619–20
   Google Scholar
• Davidoff R S. Alcohol and presynaptic inhibition in isolated spinal cord preparation. Arch Neurol 1973; 28: 60–3
   Google Scholar
• Nesteros J N. Ethanol specifically potentiates GABA-mediated neurotransmission in feline cerebral cortex. Science 1980; 209: 708–10
   Google Scholar
• Seilicovich A, Duvilanski B, Gonzales N N., et al. The effect of acute ethanol administration on GABA receptor binding in cerebellum and hypothalamus. Eur J Pharmacol 1985; 111: 365–9
   Google Scholar
• Suzdak P D., Schwartz R D., Skolnick P, Paul S M. Ethanol stimulates gamma-aminobutyric acid receptor-mediated chloride transport in rat brain synaptoneurosomes. Proc Natl Acad Sci USA 1986; 83: 4071–5
   PubMed Web of Science ®Google Scholar
• Suzdak P D., Glowa J R., Crawley J N., Schwartz R D., Skolnick P, Paul S M. A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science 1986; 234: 1243–7
   PubMed Web of Science ®Google Scholar
• Ticku M K., Rastogi S K. Barbiturate-sensitive sites on the benzodiazepine-GABA receptor-ionophore complex. Molecular and cellular mechanisms of anaesthetics, S H. Roth, K W. Miller. Plenum Press, New York 1986; 178–88
   Google Scholar
• Ticku M K., Lowrimore P, Lehoullier P. Ethanol enhances GABA-induced 36-CI-influx in primary spinal cord cultured neurons. Br Res Bull 1986; 17: 123–6
   Google Scholar
• Cott J A., Carlsson A, Engel J, Lindqvist M. Suppression of ethanol-induced locomotor stimulation by GABA-like drugs. Naunyn Schmiedebergs Arch Pharmacol 1976; 295: 203–9
   PubMed Web of Science ®Google Scholar
• Frye G D., Breese G R. GABAergic modulation of ethanol-induced motor impairment. J Pharmacol Exp Ther 1982; 223: 750–6
   PubMedGoogle Scholar
• Liljeqvist S, Engel J. Effects of GABAergic agonists and antagonists on various ethanol-induced behavioural changes. Psychopharmacology 1982; 78: 71–5
   Google Scholar
• Martz A, Deitrich R A., Harris R A. Behavioural evidence for the involvement of gamma-aminobutyric acid in the actions of ethanol. Eur J Pharmacol 1983; 89: 53–62
   PubMed Web of Science ®Google Scholar
• Ticku M K., Davis W C. Evidence that ethanol and pentobar-bital enhance 3H-diazepam binding at the benzodiazepine-GABA receptor-ionophore complex indirectly. Eur J Pharmacol 1981; 71: 521–2
   Google Scholar
• Rottenberg H. Alcohol modulation of benzodiazepine receptors. Alcohol 1985; 2: 203–7
   Google Scholar
• Lister R G., Nutt D J. Is RO 15-4513 a specific alcohol antagonist?. Trends Neurosci 1987; 10: 223–5
   Web of Science ®Google Scholar
• Lister R G., Nutt D J. Antagonising the anticonvulsant effects of ethanol using drugs that act at the benzodiaze-pine/GABA receptor complex. Pharmacol Biochem Behav 1989; 31: 751–5
   Google Scholar
• Freund G. Benzodiazepine receptor loss in brains of mice after chronic alcohol consumption. Life Sci 1980; 27: 987–92
   PubMed Web of Science ®Google Scholar
• Rastogi S K., Thyagarajan R, Clothier J, Ticku M K. The effect of chronic treatment of ethanol on benzodiazepine and picrotoxin sites on the GABA-receptor complex in regions of the brain of the rat. Neuropharmacology 1986; 25: 1179–84
   PubMed Web of Science ®Google Scholar
• Allan A M., Harris R A. Involvement of neuronal chloride channels in ethanol intoxication, tolerance and dependence. Recent developments in alcoholism, M Galanter. Trends Neurosci. 1987; 5: 313–25
   Google Scholar
• Ticku M J. Alcohol and GABA-benzodiazepine receptor function. Ann Med 1990; 22: 241–6
   PubMed Web of Science ®Google Scholar
• Cowen P J., Nutt D J. Abstinence symptoms after withdrawal of tranquillising drugs: a common neurochemical mechanism?. Lancet 1982; ii: 360–2
   Google Scholar
• Fadda F, Mosca E, Meloni R, Gessa G L. Suppression by progabide of ethanol withdrawal syndrome in rats. Eur J Pharmacol 1985; 109: 321–5
   Google Scholar
• Lister R G., Karanian J W. RO 15-4513 induces seizures in DBA/2 mice undergoing alcohol withdrawal. Alcohol 1987; 4: 409–11
   PubMed Web of Science ®Google Scholar
• Coffman J A., Petty F. Plasma GABA levels in chronic alcoholics. Am J Psychiatry 1985; 142: 1204–5
   Google Scholar
• Hawley R J., Major L F., Schulman E, Trocha P J., Takenaga J K., Catravas G N. Cerebrospinal fluid cyclic nucleotides and GABA do not change in alcohol withdrawal. Life Sci 1981; 28: 295–9
   PubMed Web of Science ®Google Scholar
• Tran V T., Snyder S H., Major L F., Hawley R J. GABA receptors are increased in the brains of alcoholics. Ann Neurol 1981; 9: 289–92
   PubMed Web of Science ®Google Scholar
• Nutt D J., Glue P. Monoamines and alcohol. Br J Addict 1986; 81: 327–38
   PubMedGoogle Scholar
• Borg S, Kvande H, Sedvall G. Central norepinephrine metabolism during alcohol intoxication in addicts and healthy volunteers. Science 1981; 213: 1135–7
   PubMed Web of Science ®Google Scholar
• Hawley R J., Major L F., Schulman E, Linnoila M. Cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol and norepinephrine levels in alcohol withdrawal. Arch Gen Psychiatry 1985; 42: 1056–62
   PubMed Web of Science ®Google Scholar
• Potter J F., Bannan L T., Beevers D G. The effect of a non-selective lipophilic beta-blocker on the blood pressure and noradrenaline, vasopressin cortisol and renin release during alcohol withdrawal. Clin Exp Hypertens [A] 1984; A6: 1147–60
   Google Scholar
• Nutt D J., Glue P, Molyneux S, Clark E. Alpha-2-adrenoceptor activity in alcohol withdrawal: a pilot study of the effects of i.v. clonidine in alcoholics and normals. Alcohol: Clin Exp Res 1988; 12: 14–18
   PubMed Web of Science ®Google Scholar
• Glue P, Sellman J D., Nicholl M G., Abbott R M., Joyce P R., Nutt D J. Studies of alpha-2-adrenoceptor function in abstinent alcoholics. Br J Addict 1989; 84: 97–102
   PubMedGoogle Scholar
• Whyte K F., Addis G J., Whitesmith R, Reid J L. Adrenergic control of plasma magnesium in man. Clin Sci 1987; 72: 135–8
   PubMed Web of Science ®Google Scholar
• Tabakoff B, Hoffman P L. Alcohol and neurotransmitters. Alcohol Tolerance and Dependence, H Rigter, J C. Crabbe. Elsevier/North Holland Biomedical Press, Amsterdam 1980
   Google Scholar
• Liljeqvist S. Changes in the sensitivity of dopamine receptors in the nucleus accumbens and in the striatum induced by chronic ethanol administration. Acta Pharmacol Toxicol 1978; 43: 19–28
   Google Scholar
• Engel J, Liljeqvist S. The effect of long term ethanol treatment on the sensitivity of dopamine receptors in the nucleus accumbens. Psychopharmacology 1976; 49: 253–7
   PubMed Web of Science ®Google Scholar
• Annunziato L, Amoroso S, Di Renzo G, et al. Increased GH responsiveness to dopamine receptor stimulation in alcohol addicts during the late withdrawal syndrome. Life Sci 1983; 33: 2651–5
   Google Scholar
• Vale W, Speiss J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981; 213: 1394–7
   PubMed Web of Science ®Google Scholar
• Koob G F., Bloom F E. Corticotropin-releasing factor and behaviour. Fed Proc 1985; 44: 259–63
   PubMedGoogle Scholar
• Weiss S RB, Post R M., Gold P W., et al. CRF-induced seizures and behaviour: interaction with amygdala kindling. Brain Res 1986; 372: 245–51
   Google Scholar
• Ehlers C L., Henriksen S, Wang M, Rivier J, Vale W, Bloom F E. Corticotropin-releasing factor increases brain excitability and convulsive seizures in the rat. Brain Res 1983; 278: 332–6
   PubMed Web of Science ®Google Scholar
• Rivier C, Bruhn R, Vale W. Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropon-releasing factor (CRF). J Pharmacol Exp Ther 1984; 229: 127–31
   PubMed Web of Science ®Google Scholar
• Dave J R., Eiden L E., Karanian J W., Eskay R L. Ethanol exposure decreases pituitary corticotropin-releasing factor binding, adenylate cyclase acjivity, proopiomelanocortin biosynthesis, and plasma beta-endorphin levels in the rat. Endocrinology 1986; 118: 280–6
   PubMed Web of Science ®Google Scholar
• Ehlers C L., Chaplin R I. Chronic ethanol exposure potentiates the locomotor-activating effects of corticotropin-releasing factor (CRF) in rats. Regul Pept 1987; 19: 345–53
   Google Scholar
• Välimäki M, Pelkonen R, Härkönen M, Ylikahri R. Hormonal changes in noncirrhotic male alcoholics during ethanol withdrawal. Alcohol and Alcoholism 1984; 19: 235–42
   PubMed Web of Science ®Google Scholar
• Risher-Flowers D, Adinoff B, Ravitz B, et al. Circadian rhythms of cortisol during alcohol withdrawal. Adv Alcohol Subst Abuse 1988; 7: 37–41
   PubMedGoogle Scholar
• Adinoff B. Hypothalamic-pituitary-adrenal axis function in recently abstinent alcoholics. In: Linnoila M, moderator: Alcohol withdrawal and noradrenergic function. Ann Intern Med 1987; 107: 875–89
   Google Scholar
• Heuser I, Von Bardeleben U, Boll E, Holsboer F. Response of ACTH and cortisol to human corticotropin-releasing hormone after short-term abstention from alcohol abuse. Biol Psychiatry 1988; 24: 316–21
   Google Scholar
• Holsboer F, Von Bardeleben U, Buller R, Heuser I, Steiger A. Stimulation response to corticotropin-releasing hormone (CRH) in patients with depression, alcoholism and panic disorder. Horm Metab Res 1987; 80–8, Suppl. 16
   Google Scholar
• Nutt D, Adinoff B, Ravitz B, et al. Cerebro-spinal fluid studies in alcoholics and violent offenders. Aust Drug Alcohol Rev 1988; 7: 105–8
   Google Scholar
• Watkins J C., Evans R H. Excitatory amino acid transmitters. Ann Rev Pharmacol Toxicol 1981; 21: 165–204
   PubMed Web of Science ®Google Scholar
• Collingridge G L., Bliss T VP. NMDA receptors - their role in long-term potentiation. Trends Neurosci 1987; 10: 288–93
   Web of Science ®Google Scholar
• Racine R J., Milgram N W., Hafner S. Long-term potentiation phenomena in the rat limbic forebrain. Brain Res 1983; 260: 217–31
   PubMed Web of Science ®Google Scholar
• Vezzani A, Wu H Q., Montena E, Samanin R. Role of the N-methyl-D-aspartate-type receptors in the development and maintenance of hippocampal kindling in rats. Neurosci Lett 1988; 87: 63–8
   Google Scholar
• Anderson W W., Swartzwelder H S., Wilson W A. The NMDA antagonist 2-amino-5-phosphonovalerate blocks stimulus train-induced epileptogenesis but not epileptiform bursting in the rat hippocampal slice. J Neurophysiol 1987; 57: 1–21
   PubMed Web of Science ®Google Scholar
• Slater N T., Stelzer A, Galvan M. Kindling-like stimulus patterns induce epileptiform discharges in the guinea pig in vitro hippocampus. Neurosci Lett 1985; 60: 25–31
   Google Scholar
• McNamara J O., Russell R D., Rigsbee L, Bonhaus D W. An-ticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models. Neuropharmacol 1988; 27: 563–8
   PubMed Web of Science ®Google Scholar
• Hoffman P L., Rabe C S., Moses F, Tabakoff B. N-methyl-D-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production. J Neurochem 1989; 52: 1937–40
   PubMed Web of Science ®Google Scholar
• Lovinger D M., White G, Weight F F. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 1989; 243: 1721–4
   PubMed Web of Science ®Google Scholar
• Franklin C L., Gruol D L. Acute ethanol alters the firing pattern and glutamate response of cerebellar Purkinje neurons in culture. Brain Res 1987; 416: 205–18
   Google Scholar
• Durand D, Carlen P L. Impairment of long-term potentiation in rat hippocampus following chronic ethanol treatment. Brain Res 1984; 308: 325–32
   Google Scholar
• Hoffman P L., Moses F, Hudspith M, Tabakoff B. Ethanol: potent and selective inhibitor of NMDA-stimulated cyclic GMP production [Abstract No. 43]. Colorado: Research Society on Alcohol Abstracts 1989; 312
   Google Scholar
• Nowak L, Bregestovski P, Ascher P, Herbert A, Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature 1984; 307: 462–5
   PubMed Web of Science ®Google Scholar
• Herron C E., Lester R AJ, Coan E J., Collingridge G L. Intracellular demonstration of an N-methyl-D-aspartate receptor mediated component of synaptic transmission in the rat hippocampus. Neurosci Lett 1985; 60: 19–23
   Google Scholar
• Flink E B. Magnesium deficiency in alcoholism. Alcohol: Clin Exp Res 1986; 10: 590–4
   PubMedGoogle Scholar
• Flink E B., McColllster R, Prasad A S., Melby J C., Doe R P. Evidences for clinical magnesium deficiency. Ann Intern Med 1957; 47: 956–68
   PubMed Web of Science ®Google Scholar
• Krystal H. The physiological basis of the treatment of delirium tremens. Am J Psychiatry 1959; 116: 137–47
   PubMed Web of Science ®Google Scholar
• Heaton F W., Pyrah L N., Beresford C C., Bryson R W., Martin D F. Hypomagnesaemia in chronic alcoholism. Lancet 1962; ii: 802–5
   Google Scholar
• Wolfe S M., Victor M. The relationship of hypomagnesaemia and alkalosis to alcohol withdrawal symptoms. Ann N Y Acad Sci 1969; 162: 973–84
   PubMed Web of Science ®Google Scholar
• Daus A T., Freeman W M., Wilson J, Aponte C. Clinical experience with 781 cases of alcoholism evaluated and treated on an inpatient basis by various methods. Int J Addict 1985; 20: 643–50
   PubMed Web of Science ®Google Scholar
• Taylor K M., Laverty R. The effect of chlordiazepoxide, diazepam and nitrazepam on catecholamine metabolism in regions of the rat brain. Eur J Pharmacol 1969; 8: 296–301
   PubMed Web of Science ®Google Scholar
• Herron C E., Williamson R, Collingridge G L. A selective N-methyl-D-aspartate antagonist depresses epileptiform activity in rat hippocampal slices. Neurosci Lett 1985; 61: 255–60
   Google Scholar
• Stelzer A, Slater N T., ten Bruggencate G. Activation of NMDA receptors blocks GABAergic inhibition in an in vitro model of epilepsy. Nature 1987; 326: 698–701
   PubMed Web of Science ®Google Scholar
• Kitazawa S, Shioda S, Nakai Y. Catecholaminergic inner-vation of neurons containing corticotropin-releasing factor in the paraventricular nucleus of the rat hypothala-mus. Acta Anat (Basel) 1987; 129: 337–43
   Google Scholar
• Alonso G, Szafarczyk A, Balmefrezol M, Assenmacher I. Immunocytochemical evidence for stimulatory control by the ventral noradrenergic bundle of parvocellular neurons of the paraventricular nucleus secreting cortictropin releasing hormone and vasopressin in rats. Brain Res 1986; 397: 297–307
   Google Scholar
• Al-Damluji S, Perry L, Tomlin S, et al. Alpha-adrenergic stimulation of corticotropin secretion by a specific central mechanism in man. Neuroendocrinology 1987; 45: 68–76
   Google Scholar
• Valentino R J., Foote S L., Aston-Jones G. Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res 1983; 270: 363–7
   PubMed Web of Science ®Google Scholar
• Brown M R., Fisher L A., Rivier J, Speiss J, Rivier C, Vale W. Corticotropin-releasing factor: effects on the sympathetic nervous system and oxygen consumption. Life Sci 1982; 30: 207–10
   Google Scholar
• Cole B J., Koob G F. Propranolol antagonises the enhanced conditioned fear produced by corticotropin releasing factor. J Pharmacol Exp Ther 1988; 247: 902–10
   PubMed Web of Science ®Google Scholar
• Jones S M., Snell L D., Johnson K M. Phencyclidine selectively inhibits N-methyl-D-aspartate-induced hippocampal (3H)norepinephrine release. J Pharmacol Exp Ther 1987; 240: 492–7
   Google Scholar
• Lalies M, Middlemiss D N., Ransom R. Stereoselective antagonism of NMDA-stimulated noradrenaline release from rat hippocampal slices by MK-801. Neurosci Lett 1988; 91: 339–42
   Google Scholar
• Araneda R, Bustos G. Modulation of dendritic release of dopamine by N-methyl-D-aspartate receptors in rat sub-stantia nigra. J Neurochem 1989; 52: 962–70
   Google Scholar
• Sellers E M., Naranjo C A., Harrison M, Devenyi P, Roach C, Sykora K. Diazepam loading: simplified treatment of alcohol withdrawal. Clin Pharmacol Ther 1983; 34: 822–6
   PubMed Web of Science ®Google Scholar
• Bjorkqvist S E. Clonidine in alcohol withdrawal. Acta Psychiatr Scand 1975; 52: 256–63
   PubMed Web of Science ®Google Scholar
• Walinder J, Balldin J, Bokstrom K, Karlsson I, Lundstrom B. Clonidine suppression of the alcohol withdrawal syndrome. Drug Alcohol Depend 1981; 8: 345–8
   Google Scholar
• Robinson B J., Robinson G M., Mating T JB, Johnson R H. Is clonidine useful in the treatment of the alcohol withdrawal?. Alcohol: Clin Exp Res 1989; 13: 95–8
   PubMed Web of Science ®Google Scholar
• Feuerlein W, Reiser E. Parameters affecting the course and results of delirium tremens treatment. Acta Psychiatr Scand 1986; 120–3, Suppl. 329
   Google Scholar
• Golbert T M., Sanz C J., Rose H D., Leitschuh T H. Comparative evaluation of treatments of alcohol withdrawal syndromes. JAMA 1967; 201: 113–6
   Web of Science ®Google Scholar
• Kaim S C., Klett C J., Rothfield B. Treatment of the acute alcohol withdrawal syndrome: a comparison of four drugs. Am J Psychiatry 1969; 125: 1640–1646
   PubMed Web of Science ®Google Scholar
• Thomas D W., Freedman D X. Treatment of the alcohol withdrawal syndrome. JAMA 1964; 188: 316–8
   Google Scholar
• Meldrum B, Anlezark G, Trimble M. Drugs modifying dopaminergic activity and behaviour, the EEG and epilepsy in Papio Papio. Eur J Pharmacol 1975; 32: 203–213
   PubMed Web of Science ®Google Scholar
• Linnoila M. Alcohol withdrawal and noradrenergic function. Ann Intern Med 1987; 107: 875–89
   PubMed Web of Science ®Google Scholar
• Sapolsky R M., Pulsinelli W A. Glucocorticoids potentiate ischaemic injury to neurons: therapeutic implications. Science 1985; 229: 1397–400
   PubMed Web of Science ®Google Scholar
• Olney J W. Excitotoxins: an overview. Excitotoxins, K Fuxe, P J. Roberts, R Schwarcz. Macmillan, London 1984; 82–96
   Google Scholar
• Walker D W., Barnes D E., Zornetzer S F., Hunter B H., Kuba-nis P. Neuronal loss in hippocampus induced by prolonged ethanol consumption in rats. Science 1980; 209: 711–3
   PubMed Web of Science ®Google Scholar